AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Bergeron, F Raymond, L Rivard, S
Citation: F. Bergeron et al., Fit in strategic information technology management research: an empirical comparison of perspectives, OMEGA-INT J, 29(2), 2001, pp. 125-142

Authors: Hubert, P Bergeron, F Ferreira, V Seligmann, M Oksenhendler, E Debre, P Autran, B
Citation: P. Hubert et al., Defective p56(Lck) activity in T cells from an adult patient with idiopathic CD4(+) lymphocytopenia, INT IMMUNOL, 12(4), 2000, pp. 449-457

Authors: Bergeron, F Leduc, R Day, R
Citation: F. Bergeron et al., Subtilase-like pro-protein convertases: from molecular specificity to therapeutic applications, J MOL ENDOC, 24(1), 2000, pp. 1-22

Authors: Trinh, BT Bergeron, F Ferron, P
Citation: Bt. Trinh et al., Long-term follow-up of cochlear implant users with ossified cochlea, J OTOLARYNG, 29(5), 2000, pp. 279-284

Authors: Bergeron, F Garsia, A Tesler, G
Citation: F. Bergeron et al., Multiple left regular representations generated by alternants, J COMB TH A, 91(1-2), 2000, pp. 49-83

Authors: Mollet, L Fautrel, B Leblond, V Bergeron, F Merle-Beral, H Baumelou, E Hubert, P Debre, P Autran, B
Citation: L. Mollet et al., Leukemic CD3(+) LGL share functional properties with their CD8(+)CD57(+) cell counterpart expanded after BMT, LEUKEMIA, 13(2), 1999, pp. 230-240

Authors: Bergeron, F Dalle, S Zhong, M Blache, P Seidah, NG Bataille, D
Citation: F. Bergeron et al., Miniglucagon-generating activity of the GH4C1 cells, M S-MED SCI, 15(5), 1999, pp. AR5-AR7

Authors: Dalle, S Smith, P Blache, P Le-Nguyen, D Le Brigand, L Bergeron, F Ashcroft, FM Bataille, D
Citation: S. Dalle et al., Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway, J BIOL CHEM, 274(16), 1999, pp. 10869-10876

Authors: Bergeron, F Bergeron, N Garsia, AM Haiman, M Tesler, G
Citation: F. Bergeron et al., Lattice diagram polynomials and extended Pieri Rules, ADV MATH, 142(2), 1999, pp. 244-334
Risultati: 1-9 |